Golzar Mobayen

Post-doctoral Researcher
Imperial College
London, England, United Kingdom

Presentation(s):

• PB0338 - Novel therapeutic antibodies targeting the C-domains of Von Willebrand Factor drives anti-thrombotic efficacy with reduced bleeding risk

  Sunday, June 23, 2024
  13:45 – 14:45 ICT